QQ客服 官方微博 反馈留言

	Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
	Yang, Shuanghui[1,2]; Li, Huan[2,3]; Xu, Ling[2,4]; Deng, Zhenhan[5]; Han, Wei[2]; Liu, Yanting[2]; Jiang, Wenqi[2]; Zu, Youli[2]
	2018
卷号	13页码:164
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4754589
专题	暨南大学
作者单位	1.[1]Cent S Univ, Xiangya Hosp, Dept Hematol, Changsha 410008, Hunan, Peoples R China 2.[2]Houston Methodist Hosp, Dept Pathol & Genom Med, 6565 Fannin St, Houston, TX 77030 USA 3.[3]Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha 410008, Hunan, Peoples R China 4.[4]Jinan Univ, Affiliated Hosp 1, Dept Hematol, Guangzhou 510632, Guangdong, Peoples R China 5.[5]Cent S Univ, Xiangya Hosp, Dept Orthopaed, Changsha 410008, Hunan, Peoples R China
推荐引用方式 GB/T 7714	Yang, Shuanghui[1,2],Li, Huan[2,3],Xu, Ling[2,4],et al. Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies[J],2018,13:164.
APA	Yang, Shuanghui[1,2].,Li, Huan[2,3].,Xu, Ling[2,4].,Deng, Zhenhan[5].,Han, Wei[2].,...&Zu, Youli[2].(2018).Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies.,13,164.
MLA	Yang, Shuanghui[1,2],et al."Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies".13(2018):164.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。